SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-005269
Filing Date
2023-06-16
Accepted
2023-06-16 16:07:00
Documents
2
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4375
2 POWER OF ATTORNEY jfedererpoa.txt EX-24 1927
  Complete submission text file 0001562180-23-005269.txt   7648
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Federer Jessica (Reporting) CIK: 0001968187 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 231021043